Dichloro(ethylenediamine)platinum(II)
CAS: 14096-51-6
Rif. 3D-PAA09651
1g | 801,00 € | ||
2g | 1.160,00 € | ||
100mg | 194,00 € | ||
250mg | 364,00 € | ||
500mg | 517,00 € |
Informazioni sul prodotto
- (SP-4-2)-Dichloro(1,2-ethanediamine-κN<sup>1</sup>,κN<sup>2</sup>)platinum
- Cpa 3
- Dichloro(1,2-diaminoethane)platinum
- Dichloro(1,2-ethanediamine)platinum
- Dichloro(ethane-1,2-diamine)platinum(II)
- Dichloroplatinum(2+) Ethane-1,2-Diyldiazanide
- Enplatin
- NSC 125181
- Platinum ethylenediamine dichloride
- Platinum(2+) Dichloride - Ethane-1,2-Diamine (1:1)
- Vedi altri sinonimi
- Platinum, dichloro(1,2-ethanediamine-N,N′)-, (SP-4-2)-
- Platinum, dichloro(1,2-ethanediamine-κN,κN′)-, (SP-4-2)-
- Platinum, dichloro(1,2-ethanediamine-κN<sup>1</sup>,κN<sup>2</sup>)-, (SP-4-2)-
- Platinum, dichloro(ethylenediamine)-
- cis-Dichloro ethylenediammine platinum
- cis-Dichloro(ethylenediamine)platinum
- cis-Dichloro(ethylenediamine)platinum(Ⅱ)
Dichloro(ethylenediamine)platinum (II) is a platinum-based anticancer drug that is used in the treatment of ovarian cancer. It binds to the phosphate group of DNA and forms a chelate ring with the DNA. This inhibits the cellular function of the DNA, preventing replication and transcription. The dichloro(ethylenediamine)platinum (II) molecule has two possible stereoisomers: cis-dichloro(ethylenediamine)platinum (II) or trans-dichloro(ethylenediamine)platinum (II). The cis form is more active than the trans form, but both are equally effective in inhibiting DNA synthesis. Dichloro(ethylenediamine)platinum (II) also reacts with chloride ions to form an ion pair complex that is taken up by cells. This complex disrupts cell metabolism and leads to apoptosis.
Proprietà chimiche
Richiesta tecnica su: 3D-PAA09651 Dichloro(ethylenediamine)platinum(II)
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.